PT  - JOURNAL ARTICLE
AU  - Alexander, Lori
ED  - Valgimigli, Marco
TI  - 3-Year Clinical Data Continue to Show Superiority of Sirolimus-Eluting versus Bare Metal Stents in STEMI Patients
DP  - 2007 Nov 01
TA  - MD Conference Express
PG  - 10--11
VI  - 7
IP  - 5
4099  - http://mdc.sagepub.com/content/7/5/10.short
4100  - http://mdc.sagepub.com/content/7/5/10.full
AB  - Results of 3 years of clinical follow-up data continued to show superiority for a combination of tirofiban+sirolimus-eluting stent (SES) vs a combination of abciximab+bare-metal stent (BMS) in STEMI patients, as evidenced by significantly reduced target vessel revascularization (TVR) rates.